Chemotherapy remains a powerful but unpleasant treatment for cancer patients, often causing severe side effects as it impacts healthy tissues alongside cancerous ones. At CU Pharmacy, Professor Tom Anchordoquy, Professor Dmitri Simberg, Dr. Scott Tilden and Dr. Madison Ricco are exploring how a specific immune response can potentially reduce the damage chemotherapy causes to healthy cells. By studying this innovative approach, they hope to make cancer treatments more targeted, effective and tolerable for patients.